RFM
NVS icon

Royal Fund Management’s Novartis NVS Stock Holding History

Royal Fund Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,362
Closed -$2.58M – 220
2022
Q1 		$2.58M Sell
29,362
-1,706
-5% -$148K 0.37% 85
2021
Q4 		$2.72M Sell
31,068
-2,533
-8% -$210K 0.39% 90
2021
Q3 		$2.75M Sell
33,601
-2,888
-8% -$260K 0.4% 86
2021
Q2 		$3.33M Buy
36,489
+2,506
+7% +$223K 0.55% 69
2021
Q1 		$2.9M Buy
33,983
+281
+0.8% +$25.2K 0.53% 73
2020
Q4 		$3.18M Sell
33,702
-1,082
-3% -$94.5K 0.67% 61
2020
Q3 		$3.02M Buy
34,784
+5,040
+17% +$437K 0.77% 58
2020
Q2 		$2.6M Buy
29,744
+830
+3% +$71.6K 0.92% 50
2020
Q1 		$2.38M Sell
28,914
-57,339
-66% -$5.12M 0.97% 37
2019
Q4 		$8.17M Buy
86,253
+1,154
+1% +$104K 2.08% 11
2019
Q3 		$7.39M Buy
85,099
+1,970
+2% +$177K 2.06% 13
2019
Q2 		$7.59M Sell
83,129
-9,296
-10% -$787K 2.25% 10
2019
Q1 		$7.96M Buy
92,425
+2,084
+2% +$167K 2.54% 7
2018
Q4 		$6.95M Sell
90,341
-14,902
-14% -$1.16M 2.82% 6
2018
Q3 		$8.13M Sell
105,243
-2,054
-2% -$152K 2.53% 7
2018
Q2 		$7.26M Sell
107,297
-2,021
-2% -$139K 2.4% 10
2018
Q1 		$7.92M Buy
109,318
+1,996
+2% +$152K 2.89% 9
2017
Q4 		$8.07M Buy
107,322
+496
+0.5% +$37.4K 2.9% 6
2017
Q3 		$8.22M Sell
106,826
-1,607
-1% -$121K 3.27% 5
2017
Q2 		$8.11M Buy
108,433
+9,276
+9% +$657K 3.44% 6
2017
Q1 		$6.6M Buy
99,157
+94,476
+2,018% +$6.3M 3.18% 11
2016
Q4 		$305K Buy
+4,681
New +$304K 0.17% 56

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Royal Fund Management's NVS Position: Q2 2022 in Review

Royal Fund Management sold out of Novartis (NVS) in Q2 2022, closing a stake of 29,362 shares — an estimated $2.58M sold.

Royal Fund Management first reported a position in NVS in Q4 2016 and held it in 22 quarters. The position peaked at $8.22M in Q3 2017. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

  • Royal Fund Management reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
  • Royal Fund Management sold 29,362 Novartis shares in Q2 2022, an estimated $2.58M.
  • Royal Fund Management first reported a position in Novartis in Q4 2016 and held it in 22 quarters.
  • Royal Fund Management's Novartis position peaked at $8.22M in Q3 2017.
  • 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Royal Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.